Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Unknown 1Terminated 1Suspended 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 4Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Fulvestrant 78pembrolizumab 77Carboplatin 73Capecitabine 69Trastuzumab 66Letrozole 62Cyclophosphamide 61Paclitaxel 60Specimen Handling 52pertuzumab 48Docetaxel 48abemaciclib 46ribociclib 44Anastrozole 35130-nm albumin-bound paclitaxel 35trastuzumab deruxtecan 34Magnetic Resonance Spectroscopy 34Tamoxifen 33Blood Specimen Collection 33sacituzumab govitecan 31exemestane 31Biopsy 31Gemcitabine 30Epirubicin 29palbociclib 28Surveys and Questionnaires 27Injections 27Drug Therapy 27pyrotinib 26eribulin 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Testosterone × Breast × Clear all
NCT06075953 2026-05-22

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
400 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡